Related Experiment Video
Updated: Nov 28, 2025

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
Different perspectives and viewpoints on the postoperative management of EGFR-mutant lung cancer
Masayuki Nakao1, Junji Ichinose1, Yosuke Matsuura1
1Department of Thoracic Surgical Oncology, Cancer Institute Hospital, The Japanese Foundation for Cancer Research, Tokyo, Japan.
No abstract available in PubMed .
More Related Videos
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Related Concept Videos
Kidney Transplant III: Nursing Management
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...